Since the related RAC1 is an activator of MEK-ERK signaling, e.g., in ovarian cancer cell EMT [97], the functional antagonism between RAC1 and RAC1B extends to the level of individual MAPK pathways. Here, RAC1 is linked to ovarian cancer.